[an error occurred while processing this directive] (none)[an error occurred while processing this directive] [an error occurred while processing this directive] [an error occurred while processing this directive]
[ Alumni - Management - Feedback - With Frills - Frames ]
DISCLAIMER: Any opinion expressed by a contributor is to be considered his/her own personal opinion, not the opinion of any other swiss-list member, the swiss-list website managers or the swiss-list committee.
Dear Startup List,
The details for our next event are now complete. see
Title: When VCs Talk About "Market Conditions," What do They Mean?
Date: September 4, 2002 at 7:00pm
Location: Wilson Sonsini, 950 Page Mill Rd., Palo Alto, CA
Cost: $20, at the door.
We'll hear from early-stage to late-stage venture investors about
funding milestones for device and biotech markets, and how Wall Street
events impact the *venture food chain* of valuations. Networking session
Chairman & CEO of Sears Capital Management, Inc.
General Partner at Apax Partners
Matthew Plunkett, Ph.D.
Associate, CIBC World Markets Healthcare Investment Banking
President & CEO, Asilomar Pharmaceuticals, Inc.
The event will be at Wilson Sonsini Goodrich and Rosati conference hall,
950 Page Mill Road, Palo Alto across from Genencor and just west of 650
Page Mill (the main WSGR building). Directions are at the RSVP page.
It will help us for planning purposes if you RSVP to rsvp_at_bioe2e.org.
Please bring cash or check. We will not be accepting advance payments
or credit cards. Receipts will be available. If you have any other
questions, please contact us at info_at_bioe2e.org
See you then,
The BioE2E Steering Committee
To unsubscribe from the startup mailing list send the
message body of "unsubscribe startup" to majordomo_at_swiss-list.com
or visit http://www.swiss-list.com/mailings/
Received on Sat Aug 31 2002 - 18:46:56 PDT